Haohai Lifesciences: A subsidiary of the holding company Three Focused Artificial Intraocular Lens Products Obtained Medical Device Registration Certificate.

Haohai Life Science announced that its holding subsidiary, Henan Saimeishi Vision Biological Technology Co., Ltd., recently received a "Medical Device Registration Certificate" for a three focal point artificial crystalline lens product issued by the National Medical Products Administration. The registration certificate is valid from June 1, 2026 to May 31, 2031. This product is suitable for vision correction of adult cataract patients without a crystalline lens. The product uses exclusive patented technology, which enhances the company's layout in the high-end multifocal artificial crystalline lens field, but it has not yet been sold and will not have a significant impact on the company's performance in the near term. There is uncertainty about future sales.